JOURNAL OF PHARMACEUTICAL SCIENCES-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1093920, encodeId=9ce7109392011, content=模式图一般放在讨论中展示还是放在结果部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093919, encodeId=fd3710939195c, content=讨论中第一段一定要撰写文章的总括么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084682, encodeId=f735108468250, content=想问下这个杂志是只能通讯作者邮箱收到返修等邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8d5b5506820, createdName=ms1000001844772998, createdTime=Mon Dec 27 15:03:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533091, encodeId=3ac5533091ce, content=麻烦问一下，一审大约需要多久啊？接收率高不高啊？好投不？谢谢您了野比大雄 2016-02-24 发表:: 研究方向：细胞吸收;; 求助一下，这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。, beContent=野比大雄 2016-02-24 发表:: 研究方向：细胞吸收;; 求助一下，这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d90f1703669, createdName=幸always福, createdTime=Mon Feb 20 13:07:00 CST 2017, time=2017-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833316, encodeId=9b3a833316d9, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：这个杂志的eab成员和科学顾问哪些是细胞吸收或重要研究方向的？ 杂志推荐审稿人好像必须要有eab成员和科学顾问。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1ed5414045, createdName=ms1700929302443684, createdTime=Mon Aug 22 22:29:30 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519453, encodeId=9fde5194530b, content=求助一下，这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=396, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Wed Feb 24 10:31:00 CST 2016, time=2016-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=827427, encodeId=9c8482e42725, content=编辑受理很快一天之内就能发出去给审稿人很不错后续期待ing , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d6c5414003, createdName=ms6032332839474392, createdTime=Tue Aug 13 21:03:00 CST 2013, time=2013-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=824521, encodeId=6ea98245214d, content=2个审稿人，1审一个月，提出的意见建议均不错，审稿人十分熟悉该领域；认真修改一个月，全部正面回应审稿意见，返回，40天后直接接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7c35414048, createdName=ms6216037977688050, createdTime=Sat Mar 16 09:38:00 CST 2013, time=2013-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=817677, encodeId=93df81e67783, content=正在投这个杂志，请问这个要求选2个审稿人的editorial advisory board网上在哪能找到呢？没有杂志的纸质版，谢谢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9195413982, createdName=ms3860263520721591, createdTime=Mon Jan 09 23:04:00 CST 2012, time=2012-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=816822, encodeId=93cb81682213, content=想问下这个杂志要求的保证书在哪里可以找到呢？主编要我发一个*证书*去还有就是要求我至少两个审稿人是编辑咨询委员会的成员这个怎么处理呢？ 非常感谢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f225414024, createdName=ms6336778790072332, createdTime=Mon Nov 07 11:31:00 CST 2011, time=2011-11-07, status=1, ipAttribution=)]

2021-12-29 Gym璨烨

模式图一般放在讨论中展示还是放在结果部分？

89 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1093920, encodeId=9ce7109392011, content=模式图一般放在讨论中展示还是放在结果部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093919, encodeId=fd3710939195c, content=讨论中第一段一定要撰写文章的总括么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084682, encodeId=f735108468250, content=想问下这个杂志是只能通讯作者邮箱收到返修等邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8d5b5506820, createdName=ms1000001844772998, createdTime=Mon Dec 27 15:03:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533091, encodeId=3ac5533091ce, content=麻烦问一下，一审大约需要多久啊？接收率高不高啊？好投不？谢谢您了野比大雄 2016-02-24 发表:: 研究方向：细胞吸收;; 求助一下，这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。, beContent=野比大雄 2016-02-24 发表:: 研究方向：细胞吸收;; 求助一下，这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d90f1703669, createdName=幸always福, createdTime=Mon Feb 20 13:07:00 CST 2017, time=2017-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833316, encodeId=9b3a833316d9, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：这个杂志的eab成员和科学顾问哪些是细胞吸收或重要研究方向的？ 杂志推荐审稿人好像必须要有eab成员和科学顾问。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1ed5414045, createdName=ms1700929302443684, createdTime=Mon Aug 22 22:29:30 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519453, encodeId=9fde5194530b, content=求助一下，这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=396, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Wed Feb 24 10:31:00 CST 2016, time=2016-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=827427, encodeId=9c8482e42725, content=编辑受理很快一天之内就能发出去给审稿人很不错后续期待ing , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d6c5414003, createdName=ms6032332839474392, createdTime=Tue Aug 13 21:03:00 CST 2013, time=2013-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=824521, encodeId=6ea98245214d, content=2个审稿人，1审一个月，提出的意见建议均不错，审稿人十分熟悉该领域；认真修改一个月，全部正面回应审稿意见，返回，40天后直接接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7c35414048, createdName=ms6216037977688050, createdTime=Sat Mar 16 09:38:00 CST 2013, time=2013-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=817677, encodeId=93df81e67783, content=正在投这个杂志，请问这个要求选2个审稿人的editorial advisory board网上在哪能找到呢？没有杂志的纸质版，谢谢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9195413982, createdName=ms3860263520721591, createdTime=Mon Jan 09 23:04:00 CST 2012, time=2012-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=816822, encodeId=93cb81682213, content=想问下这个杂志要求的保证书在哪里可以找到呢？主编要我发一个*证书*去还有就是要求我至少两个审稿人是编辑咨询委员会的成员这个怎么处理呢？ 非常感谢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f225414024, createdName=ms6336778790072332, createdTime=Mon Nov 07 11:31:00 CST 2011, time=2011-11-07, status=1, ipAttribution=)]

2021-12-27 MS68862005

讨论中第一段一定要撰写文章的总括么？

83 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1093920, encodeId=9ce7109392011, content=模式图一般放在讨论中展示还是放在结果部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093919, encodeId=fd3710939195c, content=讨论中第一段一定要撰写文章的总括么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084682, encodeId=f735108468250, content=想问下这个杂志是只能通讯作者邮箱收到返修等邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8d5b5506820, createdName=ms1000001844772998, createdTime=Mon Dec 27 15:03:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533091, encodeId=3ac5533091ce, content=麻烦问一下，一审大约需要多久啊？接收率高不高啊？好投不？谢谢您了野比大雄 2016-02-24 发表:: 研究方向：细胞吸收;; 求助一下，这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。, beContent=野比大雄 2016-02-24 发表:: 研究方向：细胞吸收;; 求助一下，这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d90f1703669, createdName=幸always福, createdTime=Mon Feb 20 13:07:00 CST 2017, time=2017-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833316, encodeId=9b3a833316d9, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：这个杂志的eab成员和科学顾问哪些是细胞吸收或重要研究方向的？ 杂志推荐审稿人好像必须要有eab成员和科学顾问。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1ed5414045, createdName=ms1700929302443684, createdTime=Mon Aug 22 22:29:30 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519453, encodeId=9fde5194530b, content=求助一下，这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=396, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Wed Feb 24 10:31:00 CST 2016, time=2016-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=827427, encodeId=9c8482e42725, content=编辑受理很快一天之内就能发出去给审稿人很不错后续期待ing , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d6c5414003, createdName=ms6032332839474392, createdTime=Tue Aug 13 21:03:00 CST 2013, time=2013-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=824521, encodeId=6ea98245214d, content=2个审稿人，1审一个月，提出的意见建议均不错，审稿人十分熟悉该领域；认真修改一个月，全部正面回应审稿意见，返回，40天后直接接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7c35414048, createdName=ms6216037977688050, createdTime=Sat Mar 16 09:38:00 CST 2013, time=2013-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=817677, encodeId=93df81e67783, content=正在投这个杂志，请问这个要求选2个审稿人的editorial advisory board网上在哪能找到呢？没有杂志的纸质版，谢谢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9195413982, createdName=ms3860263520721591, createdTime=Mon Jan 09 23:04:00 CST 2012, time=2012-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=816822, encodeId=93cb81682213, content=想问下这个杂志要求的保证书在哪里可以找到呢？主编要我发一个*证书*去还有就是要求我至少两个审稿人是编辑咨询委员会的成员这个怎么处理呢？ 非常感谢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f225414024, createdName=ms6336778790072332, createdTime=Mon Nov 07 11:31:00 CST 2011, time=2011-11-07, status=1, ipAttribution=)]

2021-12-27 ms1000001844772998

想问下这个杂志是只能通讯作者邮箱收到返修等邮件吗？

85 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1093920, encodeId=9ce7109392011, content=模式图一般放在讨论中展示还是放在结果部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093919, encodeId=fd3710939195c, content=讨论中第一段一定要撰写文章的总括么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084682, encodeId=f735108468250, content=想问下这个杂志是只能通讯作者邮箱收到返修等邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8d5b5506820, createdName=ms1000001844772998, createdTime=Mon Dec 27 15:03:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533091, encodeId=3ac5533091ce, content=麻烦问一下，一审大约需要多久啊？接收率高不高啊？好投不？谢谢您了野比大雄 2016-02-24 发表:: 研究方向：细胞吸收;; 求助一下，这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。, beContent=野比大雄 2016-02-24 发表:: 研究方向：细胞吸收;; 求助一下，这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d90f1703669, createdName=幸always福, createdTime=Mon Feb 20 13:07:00 CST 2017, time=2017-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833316, encodeId=9b3a833316d9, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：这个杂志的eab成员和科学顾问哪些是细胞吸收或重要研究方向的？ 杂志推荐审稿人好像必须要有eab成员和科学顾问。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1ed5414045, createdName=ms1700929302443684, createdTime=Mon Aug 22 22:29:30 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519453, encodeId=9fde5194530b, content=求助一下，这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=396, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Wed Feb 24 10:31:00 CST 2016, time=2016-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=827427, encodeId=9c8482e42725, content=编辑受理很快一天之内就能发出去给审稿人很不错后续期待ing , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d6c5414003, createdName=ms6032332839474392, createdTime=Tue Aug 13 21:03:00 CST 2013, time=2013-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=824521, encodeId=6ea98245214d, content=2个审稿人，1审一个月，提出的意见建议均不错，审稿人十分熟悉该领域；认真修改一个月，全部正面回应审稿意见，返回，40天后直接接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7c35414048, createdName=ms6216037977688050, createdTime=Sat Mar 16 09:38:00 CST 2013, time=2013-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=817677, encodeId=93df81e67783, content=正在投这个杂志，请问这个要求选2个审稿人的editorial advisory board网上在哪能找到呢？没有杂志的纸质版，谢谢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9195413982, createdName=ms3860263520721591, createdTime=Mon Jan 09 23:04:00 CST 2012, time=2012-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=816822, encodeId=93cb81682213, content=想问下这个杂志要求的保证书在哪里可以找到呢？主编要我发一个*证书*去还有就是要求我至少两个审稿人是编辑咨询委员会的成员这个怎么处理呢？ 非常感谢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f225414024, createdName=ms6336778790072332, createdTime=Mon Nov 07 11:31:00 CST 2011, time=2011-11-07, status=1, ipAttribution=)]

2017-02-20 幸always福

麻烦问一下，一审大约需要多久啊？接收率高不高啊？好投不？谢谢您了野比大雄 2016-02-24 发表::
研究方向：细胞吸收;; 求助一下，这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。

野比大雄 2016-02-24 发表:: 研究方向：细胞吸收;; 求助一下，这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。

435 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1093920, encodeId=9ce7109392011, content=模式图一般放在讨论中展示还是放在结果部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093919, encodeId=fd3710939195c, content=讨论中第一段一定要撰写文章的总括么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084682, encodeId=f735108468250, content=想问下这个杂志是只能通讯作者邮箱收到返修等邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8d5b5506820, createdName=ms1000001844772998, createdTime=Mon Dec 27 15:03:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533091, encodeId=3ac5533091ce, content=麻烦问一下，一审大约需要多久啊？接收率高不高啊？好投不？谢谢您了野比大雄 2016-02-24 发表:: 研究方向：细胞吸收;; 求助一下，这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。, beContent=野比大雄 2016-02-24 发表:: 研究方向：细胞吸收;; 求助一下，这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d90f1703669, createdName=幸always福, createdTime=Mon Feb 20 13:07:00 CST 2017, time=2017-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833316, encodeId=9b3a833316d9, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：这个杂志的eab成员和科学顾问哪些是细胞吸收或重要研究方向的？ 杂志推荐审稿人好像必须要有eab成员和科学顾问。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1ed5414045, createdName=ms1700929302443684, createdTime=Mon Aug 22 22:29:30 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519453, encodeId=9fde5194530b, content=求助一下，这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=396, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Wed Feb 24 10:31:00 CST 2016, time=2016-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=827427, encodeId=9c8482e42725, content=编辑受理很快一天之内就能发出去给审稿人很不错后续期待ing , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d6c5414003, createdName=ms6032332839474392, createdTime=Tue Aug 13 21:03:00 CST 2013, time=2013-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=824521, encodeId=6ea98245214d, content=2个审稿人，1审一个月，提出的意见建议均不错，审稿人十分熟悉该领域；认真修改一个月，全部正面回应审稿意见，返回，40天后直接接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7c35414048, createdName=ms6216037977688050, createdTime=Sat Mar 16 09:38:00 CST 2013, time=2013-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=817677, encodeId=93df81e67783, content=正在投这个杂志，请问这个要求选2个审稿人的editorial advisory board网上在哪能找到呢？没有杂志的纸质版，谢谢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9195413982, createdName=ms3860263520721591, createdTime=Mon Jan 09 23:04:00 CST 2012, time=2012-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=816822, encodeId=93cb81682213, content=想问下这个杂志要求的保证书在哪里可以找到呢？主编要我发一个*证书*去还有就是要求我至少两个审稿人是编辑咨询委员会的成员这个怎么处理呢？ 非常感谢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f225414024, createdName=ms6336778790072332, createdTime=Mon Nov 07 11:31:00 CST 2011, time=2011-11-07, status=1, ipAttribution=)]

2016-08-22 ms1700929302443684

审稿速度:2.0 | 投稿命中率:50.0
经验分享：这个杂志的eab成员和科学顾问哪些是细胞吸收或重要研究方向的？
杂志推荐审稿人好像必须要有eab成员和科学顾问。

170 0

[GetPortalCommentsPageByObjectIdResponse(id=1093920, encodeId=9ce7109392011, content=模式图一般放在讨论中展示还是放在结果部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093919, encodeId=fd3710939195c, content=讨论中第一段一定要撰写文章的总括么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084682, encodeId=f735108468250, content=想问下这个杂志是只能通讯作者邮箱收到返修等邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8d5b5506820, createdName=ms1000001844772998, createdTime=Mon Dec 27 15:03:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533091, encodeId=3ac5533091ce, content=麻烦问一下，一审大约需要多久啊？接收率高不高啊？好投不？谢谢您了野比大雄 2016-02-24 发表:: 研究方向：细胞吸收;; 求助一下，这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。, beContent=野比大雄 2016-02-24 发表:: 研究方向：细胞吸收;; 求助一下，这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d90f1703669, createdName=幸always福, createdTime=Mon Feb 20 13:07:00 CST 2017, time=2017-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833316, encodeId=9b3a833316d9, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：这个杂志的eab成员和科学顾问哪些是细胞吸收或重要研究方向的？ 杂志推荐审稿人好像必须要有eab成员和科学顾问。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1ed5414045, createdName=ms1700929302443684, createdTime=Mon Aug 22 22:29:30 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519453, encodeId=9fde5194530b, content=求助一下，这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=396, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Wed Feb 24 10:31:00 CST 2016, time=2016-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=827427, encodeId=9c8482e42725, content=编辑受理很快一天之内就能发出去给审稿人很不错后续期待ing , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d6c5414003, createdName=ms6032332839474392, createdTime=Tue Aug 13 21:03:00 CST 2013, time=2013-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=824521, encodeId=6ea98245214d, content=2个审稿人，1审一个月，提出的意见建议均不错，审稿人十分熟悉该领域；认真修改一个月，全部正面回应审稿意见，返回，40天后直接接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7c35414048, createdName=ms6216037977688050, createdTime=Sat Mar 16 09:38:00 CST 2013, time=2013-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=817677, encodeId=93df81e67783, content=正在投这个杂志，请问这个要求选2个审稿人的editorial advisory board网上在哪能找到呢？没有杂志的纸质版，谢谢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9195413982, createdName=ms3860263520721591, createdTime=Mon Jan 09 23:04:00 CST 2012, time=2012-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=816822, encodeId=93cb81682213, content=想问下这个杂志要求的保证书在哪里可以找到呢？主编要我发一个*证书*去还有就是要求我至少两个审稿人是编辑咨询委员会的成员这个怎么处理呢？ 非常感谢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f225414024, createdName=ms6336778790072332, createdTime=Mon Nov 07 11:31:00 CST 2011, time=2011-11-07, status=1, ipAttribution=)]

2016-02-24 野比大雄

求助一下，这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。

396 0

[GetPortalCommentsPageByObjectIdResponse(id=1093920, encodeId=9ce7109392011, content=模式图一般放在讨论中展示还是放在结果部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093919, encodeId=fd3710939195c, content=讨论中第一段一定要撰写文章的总括么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084682, encodeId=f735108468250, content=想问下这个杂志是只能通讯作者邮箱收到返修等邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8d5b5506820, createdName=ms1000001844772998, createdTime=Mon Dec 27 15:03:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533091, encodeId=3ac5533091ce, content=麻烦问一下，一审大约需要多久啊？接收率高不高啊？好投不？谢谢您了野比大雄 2016-02-24 发表:: 研究方向：细胞吸收;; 求助一下，这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。, beContent=野比大雄 2016-02-24 发表:: 研究方向：细胞吸收;; 求助一下，这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d90f1703669, createdName=幸always福, createdTime=Mon Feb 20 13:07:00 CST 2017, time=2017-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833316, encodeId=9b3a833316d9, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：这个杂志的eab成员和科学顾问哪些是细胞吸收或重要研究方向的？ 杂志推荐审稿人好像必须要有eab成员和科学顾问。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1ed5414045, createdName=ms1700929302443684, createdTime=Mon Aug 22 22:29:30 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519453, encodeId=9fde5194530b, content=求助一下，这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=396, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Wed Feb 24 10:31:00 CST 2016, time=2016-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=827427, encodeId=9c8482e42725, content=编辑受理很快一天之内就能发出去给审稿人很不错后续期待ing , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d6c5414003, createdName=ms6032332839474392, createdTime=Tue Aug 13 21:03:00 CST 2013, time=2013-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=824521, encodeId=6ea98245214d, content=2个审稿人，1审一个月，提出的意见建议均不错，审稿人十分熟悉该领域；认真修改一个月，全部正面回应审稿意见，返回，40天后直接接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7c35414048, createdName=ms6216037977688050, createdTime=Sat Mar 16 09:38:00 CST 2013, time=2013-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=817677, encodeId=93df81e67783, content=正在投这个杂志，请问这个要求选2个审稿人的editorial advisory board网上在哪能找到呢？没有杂志的纸质版，谢谢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9195413982, createdName=ms3860263520721591, createdTime=Mon Jan 09 23:04:00 CST 2012, time=2012-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=816822, encodeId=93cb81682213, content=想问下这个杂志要求的保证书在哪里可以找到呢？主编要我发一个*证书*去还有就是要求我至少两个审稿人是编辑咨询委员会的成员这个怎么处理呢？ 非常感谢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f225414024, createdName=ms6336778790072332, createdTime=Mon Nov 07 11:31:00 CST 2011, time=2011-11-07, status=1, ipAttribution=)]

2013-08-13 ms6032332839474392

编辑受理很快一天之内就能发出去给审稿人很不错后续期待ing

141 0

[GetPortalCommentsPageByObjectIdResponse(id=1093920, encodeId=9ce7109392011, content=模式图一般放在讨论中展示还是放在结果部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093919, encodeId=fd3710939195c, content=讨论中第一段一定要撰写文章的总括么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084682, encodeId=f735108468250, content=想问下这个杂志是只能通讯作者邮箱收到返修等邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8d5b5506820, createdName=ms1000001844772998, createdTime=Mon Dec 27 15:03:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533091, encodeId=3ac5533091ce, content=麻烦问一下，一审大约需要多久啊？接收率高不高啊？好投不？谢谢您了野比大雄 2016-02-24 发表:: 研究方向：细胞吸收;; 求助一下，这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。, beContent=野比大雄 2016-02-24 发表:: 研究方向：细胞吸收;; 求助一下，这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d90f1703669, createdName=幸always福, createdTime=Mon Feb 20 13:07:00 CST 2017, time=2017-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833316, encodeId=9b3a833316d9, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：这个杂志的eab成员和科学顾问哪些是细胞吸收或重要研究方向的？ 杂志推荐审稿人好像必须要有eab成员和科学顾问。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1ed5414045, createdName=ms1700929302443684, createdTime=Mon Aug 22 22:29:30 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519453, encodeId=9fde5194530b, content=求助一下，这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=396, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Wed Feb 24 10:31:00 CST 2016, time=2016-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=827427, encodeId=9c8482e42725, content=编辑受理很快一天之内就能发出去给审稿人很不错后续期待ing , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d6c5414003, createdName=ms6032332839474392, createdTime=Tue Aug 13 21:03:00 CST 2013, time=2013-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=824521, encodeId=6ea98245214d, content=2个审稿人，1审一个月，提出的意见建议均不错，审稿人十分熟悉该领域；认真修改一个月，全部正面回应审稿意见，返回，40天后直接接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7c35414048, createdName=ms6216037977688050, createdTime=Sat Mar 16 09:38:00 CST 2013, time=2013-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=817677, encodeId=93df81e67783, content=正在投这个杂志，请问这个要求选2个审稿人的editorial advisory board网上在哪能找到呢？没有杂志的纸质版，谢谢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9195413982, createdName=ms3860263520721591, createdTime=Mon Jan 09 23:04:00 CST 2012, time=2012-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=816822, encodeId=93cb81682213, content=想问下这个杂志要求的保证书在哪里可以找到呢？主编要我发一个*证书*去还有就是要求我至少两个审稿人是编辑咨询委员会的成员这个怎么处理呢？ 非常感谢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f225414024, createdName=ms6336778790072332, createdTime=Mon Nov 07 11:31:00 CST 2011, time=2011-11-07, status=1, ipAttribution=)]

2013-03-16 ms6216037977688050

2个审稿人，1审一个月，提出的意见建议均不错，审稿人十分熟悉该领域；认真修改一个月，全部正面回应审稿意见，返回，40天后直接接收。

129 0

[GetPortalCommentsPageByObjectIdResponse(id=1093920, encodeId=9ce7109392011, content=模式图一般放在讨论中展示还是放在结果部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093919, encodeId=fd3710939195c, content=讨论中第一段一定要撰写文章的总括么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084682, encodeId=f735108468250, content=想问下这个杂志是只能通讯作者邮箱收到返修等邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8d5b5506820, createdName=ms1000001844772998, createdTime=Mon Dec 27 15:03:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533091, encodeId=3ac5533091ce, content=麻烦问一下，一审大约需要多久啊？接收率高不高啊？好投不？谢谢您了野比大雄 2016-02-24 发表:: 研究方向：细胞吸收;; 求助一下，这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。, beContent=野比大雄 2016-02-24 发表:: 研究方向：细胞吸收;; 求助一下，这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d90f1703669, createdName=幸always福, createdTime=Mon Feb 20 13:07:00 CST 2017, time=2017-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833316, encodeId=9b3a833316d9, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：这个杂志的eab成员和科学顾问哪些是细胞吸收或重要研究方向的？ 杂志推荐审稿人好像必须要有eab成员和科学顾问。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1ed5414045, createdName=ms1700929302443684, createdTime=Mon Aug 22 22:29:30 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519453, encodeId=9fde5194530b, content=求助一下，这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=396, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Wed Feb 24 10:31:00 CST 2016, time=2016-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=827427, encodeId=9c8482e42725, content=编辑受理很快一天之内就能发出去给审稿人很不错后续期待ing , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d6c5414003, createdName=ms6032332839474392, createdTime=Tue Aug 13 21:03:00 CST 2013, time=2013-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=824521, encodeId=6ea98245214d, content=2个审稿人，1审一个月，提出的意见建议均不错，审稿人十分熟悉该领域；认真修改一个月，全部正面回应审稿意见，返回，40天后直接接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7c35414048, createdName=ms6216037977688050, createdTime=Sat Mar 16 09:38:00 CST 2013, time=2013-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=817677, encodeId=93df81e67783, content=正在投这个杂志，请问这个要求选2个审稿人的editorial advisory board网上在哪能找到呢？没有杂志的纸质版，谢谢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9195413982, createdName=ms3860263520721591, createdTime=Mon Jan 09 23:04:00 CST 2012, time=2012-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=816822, encodeId=93cb81682213, content=想问下这个杂志要求的保证书在哪里可以找到呢？主编要我发一个*证书*去还有就是要求我至少两个审稿人是编辑咨询委员会的成员这个怎么处理呢？ 非常感谢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f225414024, createdName=ms6336778790072332, createdTime=Mon Nov 07 11:31:00 CST 2011, time=2011-11-07, status=1, ipAttribution=)]

2012-01-09 ms3860263520721591

正在投这个杂志，请问这个要求选2个审稿人的editorial advisory board网上在哪能找到呢？没有杂志的纸质版，谢谢

121 0

[GetPortalCommentsPageByObjectIdResponse(id=1093920, encodeId=9ce7109392011, content=模式图一般放在讨论中展示还是放在结果部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093919, encodeId=fd3710939195c, content=讨论中第一段一定要撰写文章的总括么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084682, encodeId=f735108468250, content=想问下这个杂志是只能通讯作者邮箱收到返修等邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8d5b5506820, createdName=ms1000001844772998, createdTime=Mon Dec 27 15:03:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533091, encodeId=3ac5533091ce, content=麻烦问一下，一审大约需要多久啊？接收率高不高啊？好投不？谢谢您了野比大雄 2016-02-24 发表:: 研究方向：细胞吸收;; 求助一下，这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。, beContent=野比大雄 2016-02-24 发表:: 研究方向：细胞吸收;; 求助一下，这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=435, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d90f1703669, createdName=幸always福, createdTime=Mon Feb 20 13:07:00 CST 2017, time=2017-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833316, encodeId=9b3a833316d9, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：这个杂志的eab成员和科学顾问哪些是细胞吸收或重要研究方向的？ 杂志推荐审稿人好像必须要有eab成员和科学顾问。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1ed5414045, createdName=ms1700929302443684, createdTime=Mon Aug 22 22:29:30 CST 2016, time=2016-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519453, encodeId=9fde5194530b, content=求助一下，这个杂志的EAB成员和科学顾问哪些是细胞吸收或重要研究方向的。杂志推荐审稿人好像必须要有EAB成员和科学顾问。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=396, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f901690753, createdName=野比大雄, createdTime=Wed Feb 24 10:31:00 CST 2016, time=2016-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=827427, encodeId=9c8482e42725, content=编辑受理很快一天之内就能发出去给审稿人很不错后续期待ing , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d6c5414003, createdName=ms6032332839474392, createdTime=Tue Aug 13 21:03:00 CST 2013, time=2013-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=824521, encodeId=6ea98245214d, content=2个审稿人，1审一个月，提出的意见建议均不错，审稿人十分熟悉该领域；认真修改一个月，全部正面回应审稿意见，返回，40天后直接接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7c35414048, createdName=ms6216037977688050, createdTime=Sat Mar 16 09:38:00 CST 2013, time=2013-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=817677, encodeId=93df81e67783, content=正在投这个杂志，请问这个要求选2个审稿人的editorial advisory board网上在哪能找到呢？没有杂志的纸质版，谢谢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9195413982, createdName=ms3860263520721591, createdTime=Mon Jan 09 23:04:00 CST 2012, time=2012-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=816822, encodeId=93cb81682213, content=想问下这个杂志要求的保证书在哪里可以找到呢？主编要我发一个*证书*去还有就是要求我至少两个审稿人是编辑咨询委员会的成员这个怎么处理呢？ 非常感谢 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f225414024, createdName=ms6336778790072332, createdTime=Mon Nov 07 11:31:00 CST 2011, time=2011-11-07, status=1, ipAttribution=)]

2011-11-07 ms6336778790072332

想问下这个杂志要求的保证书在哪里可以找到呢？主编要我发一个*证书*去还有就是要求我至少两个审稿人是编辑咨询委员会的成员这个怎么处理呢？
非常感谢

136 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务